A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - Wegovy users could lose more than 10% of their body weight after a year on the ...

Pharma firms like Lilly, Roche and Pfizer are racing to develop weight loss pills. Blockbuster injections like Ozempic, Wegovy, Mounjaro and Zepbound—brand names for the drugs semaglutide and ...

The company’s shares jumped 15% in the wake of the trials which showed the pill, called orforglipron, helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable ...

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

Those getting the pill hadn’t hit a weight plateau when the study ended, suggesting they may lose even more, the company said in a statement. Blood sugar levels fell by an average of 1.3% ...

Share on Pinterest Novo Nordisk’s new weight loss pill, amycretin, has had promising results in an early clinical trial. Image credit: SERGEI GAPON/Getty Images. Amycretin, a new weight loss ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers ...